Replimune Group, Inc. (REPL)
13.07
-0.35
(-2.61%)
USD |
NASDAQ |
Oct 12, 16:00
13.07
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Market Cap : 1.098B for Oct. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 12, 2026 | 1.098B |
| October 09, 2026 | 1.127B |
| October 08, 2026 | 1.095B |
| October 07, 2026 | 1.109B |
| October 06, 2026 | 1.113B |
| October 05, 2026 | 1.104B |
| October 02, 2026 | 1.098B |
| October 01, 2026 | 1.130B |
| September 30, 2026 | 1.112B |
| September 29, 2026 | 1.092B |
| September 28, 2026 | 1.055B |
| September 25, 2026 | 1.038B |
| September 24, 2026 | 1.058B |
| September 23, 2026 | 1.088B |
| September 22, 2026 | 1.131B |
| September 21, 2026 | 1.081B |
| September 18, 2026 | 1.098B |
| September 17, 2026 | 1.081B |
| September 16, 2026 | 1.088B |
| September 15, 2026 | 1.094B |
| September 14, 2026 | 1.101B |
| September 11, 2026 | 1.085B |
| September 10, 2026 | 1.112B |
| September 09, 2026 | 1.214B |
| September 08, 2026 | 1.240B |
| Date | Value |
|---|---|
| September 04, 2026 | 1.263B |
| September 03, 2026 | 1.284B |
| September 02, 2026 | 1.342B |
| September 01, 2026 | 1.316B |
| August 31, 2026 | 1.285B |
| August 28, 2026 | 1.302B |
| August 27, 2026 | 1.310B |
| August 26, 2026 | 1.334B |
| August 25, 2026 | 1.327B |
| August 24, 2026 | 1.235B |
| August 21, 2026 | 1.240B |
| August 20, 2026 | 1.180B |
| August 19, 2026 | 1.244B |
| August 18, 2026 | 1.308B |
| August 17, 2026 | 1.229B |
| August 14, 2026 | 1.257B |
| August 13, 2026 | 1.276B |
| August 12, 2026 | 1.280B |
| August 11, 2026 | 1.129B |
| August 10, 2026 | 1.131B |
| August 07, 2026 | 997.57M |
| August 06, 2026 | 1.064B |
| August 05, 2026 | 978.54M |
| August 04, 2026 | 985.99M |
| August 03, 2026 | 985.16M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Kalaris Therapeutics, Inc. | 53.80M |
| Arrowhead Pharmaceuticals, Inc. | 8.571B |
| Oncolytics Biotech, Inc. | 58.99M |
| Sangamo Therapeutics, Inc. | 62.14M |
| Sarepta Therapeutics, Inc. | 1.842B |
Market Cap Related Metrics
| Price to Book Value | 10.39 |
| Price | 13.07 |
| Earnings Yield | -25.09% |